Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AMN Healthcare Services filings document operating results, governance matters, capital-structure disclosures, and material events for a healthcare workforce solutions company. Form 8-K reports include quarterly and annual financial results, Regulation FD investor presentation materials, board and officer matters, and amendments to corporate bylaws.
The company's proxy materials cover annual meeting voting, board composition, shareholder proposal procedures, director nomination mechanics, governance practices, performance discussion, and capital allocation priorities. Filings also disclose segment activity across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions, along with debt, leverage, liquidity, and risk-related reporting.
Huber Celia P reported acquisition or exercise transactions in this Form 4 filing.
AMN Healthcare Services director Celia P. Huber received a grant of 8,304 restricted stock units (RSUs) of AMN common stock as equity compensation. Each RSU represents one share of common stock and will vest on the earlier of one year from the May 1, 2026 grant date or the company’s 2027 Annual Meeting of Shareholders, aligning her interests with long-term shareholder value.
AMN Healthcare Services, Inc. reported the results of its Annual Meeting of Shareholders held on May 1, 2026. Shareholders approved Amendment No. 1 to the AMN Healthcare 2025 Equity Plan, which had previously been approved by the Board subject to shareholder approval.
All nine director nominees received strong support, with individual "for" votes generally around 27–29 million and broker non-votes of 4,410,527 for each nominee. In total, shareholders voted on five proposals, with detailed for, against, abstain, and broker non-vote tallies disclosed and further descriptions of each proposal referenced in the company’s Definitive Proxy Statement filed on March 18, 2026.
AMN Healthcare Services Inc director Eric P. Palmer filed an initial Form 3 reporting his beneficial ownership in the company. The filing lists his holdings of Common Stock as zero, with 0 shares owned directly following the reported position.
AMN Healthcare Services Inc reported a Schedule 13G ownership filing by Vanguard Capital Management. Vanguard reported 1,960,648 shares beneficially owned as of 03/31/2026, representing 5.07% of the class. Vanguard: sole dispositive power over 1,960,648 shares and sole voting power for 283,222 shares.
The filing notes these holdings reflect securities managed across Vanguard Capital Management LLC and affiliated investment divisions and includes shares held by Vanguard funds and managed accounts. The report was signed on 04/29/2026.
The Vanguard Group filed an amendment to a Schedule 13G/A reporting its holdings in AMN Healthcare Services Inc common stock and states it beneficially owns 0 shares (0%) following an internal realignment effective January 12, 2026. The filing explains certain Vanguard subsidiaries will report holdings separately in accordance with SEC Release No. 34-39538.
AMN Healthcare is asking shareholders to vote on five items at its 2026 virtual annual meeting on May 1, 2026. Proposals include electing nine directors, an advisory approval of 2025 executive pay, ratifying KPMG as auditor for 2026, approving an amendment to the 2025 Equity Plan, and a shareholder proposal the Board opposes.
The company highlights 2025 results of $2.7 billion in revenue, $234 million in adjusted EBITDA and $269 million in free cash flow, along with a $285 million reduction in net debt. Management emphasizes technology platforms like WorkWise, ShiftWise Flex and AMN Passport, growing use of AI, and high client and employee satisfaction scores.
Governance features include an independent board chair, annual director elections, majority voting with a resignation policy, proxy access, an aggregate tenure guideline of under ten years for independent directors, and stock ownership guidelines for directors and executives. The Board also outlines its risk oversight, cybersecurity and data privacy programs, sustainability and social impact priorities, and director compensation structure.
AMN Healthcare Services, Inc. files its Annual Report describing a broad U.S. healthcare staffing and workforce solutions business spanning nurse and allied staffing, locum tenens, interim leadership, language services, managed services programs, vendor management systems and recruitment solutions.
The company highlights significant technology investments, including its WorkWise platform, ShiftWise Flex VMS, AMN Passport app and an Event Management System for strike coverage, as well as growing use of automation and AI. Human capital initiatives focus on well-being, development, employee resource groups and diversity.
Risk factors emphasize economic cycles, labor shortages, regulatory and reimbursement changes, technology disruption, cyber and privacy risks, wage-and-hour and malpractice exposure, and high client concentration, with Kaiser accounting for about 22% of 2025 consolidated revenue. The report also notes a $109.5 million goodwill impairment and total indebtedness of $767.1 million as of December 31, 2025.
AMN Healthcare Services, Inc. files its Annual Report describing a broad U.S. healthcare staffing and workforce solutions business spanning nurse and allied staffing, locum tenens, interim leadership, language services, managed services programs, vendor management systems and recruitment solutions.
The company highlights significant technology investments, including its WorkWise platform, ShiftWise Flex VMS, AMN Passport app and an Event Management System for strike coverage, as well as growing use of automation and AI. Human capital initiatives focus on well-being, development, employee resource groups and diversity.
Risk factors emphasize economic cycles, labor shortages, regulatory and reimbursement changes, technology disruption, cyber and privacy risks, wage-and-hour and malpractice exposure, and high client concentration, with Kaiser accounting for about 22% of 2025 consolidated revenue. The report also notes a $109.5 million goodwill impairment and total indebtedness of $767.1 million as of December 31, 2025.
AMN Healthcare reported mixed fourth quarter and full-year 2025 results, with growth in some areas but sharply lower profitability. Q4 2025 revenue was $748 million, up 2% year over year and 18% sequentially, helped by $124 million of labor disruption revenue in Nurse and Allied Solutions. The quarter still produced a net loss of $7.7 million, or ($0.20) per share, while adjusted diluted EPS fell to $0.22, down 70% from the prior year period.
For full year 2025, revenue was $2.730 billion, down 8%, and AMN recorded a net loss of $95.7 million, or ($2.48) per share. Adjusted diluted EPS dropped to $1.36 from $3.31 in 2024, and adjusted EBITDA declined 31% to $234.5 million as gross margin compressed to 28.3%. Despite weaker earnings, cash flow from operations reached $269 million and total debt was reduced by $285 million to $775 million. For first quarter 2026, the company guides revenue to $1.225–$1.240 billion with an adjusted EBITDA margin of 9.7%–10.2%.
AMN Healthcare reported mixed fourth quarter and full-year 2025 results, with growth in some areas but sharply lower profitability. Q4 2025 revenue was $748 million, up 2% year over year and 18% sequentially, helped by $124 million of labor disruption revenue in Nurse and Allied Solutions. The quarter still produced a net loss of $7.7 million, or ($0.20) per share, while adjusted diluted EPS fell to $0.22, down 70% from the prior year period.
For full year 2025, revenue was $2.730 billion, down 8%, and AMN recorded a net loss of $95.7 million, or ($2.48) per share. Adjusted diluted EPS dropped to $1.36 from $3.31 in 2024, and adjusted EBITDA declined 31% to $234.5 million as gross margin compressed to 28.3%. Despite weaker earnings, cash flow from operations reached $269 million and total debt was reduced by $285 million to $775 million. For first quarter 2026, the company guides revenue to $1.225–$1.240 billion with an adjusted EBITDA margin of 9.7%–10.2%.
AMN Healthcare Services, Inc. received an amended Schedule 13G from investment entities associated with Millennium. Integrated Core Strategies (US) LLC reports beneficial ownership of 1,780,744 shares of common stock, representing 4.6% of the class.
Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 2,005,966 shares, or 5.2% of the common stock. The filing states that, as of December 31, 2025, the reporting persons ceased to be beneficial owners of more than 5% of AMN’s outstanding common stock and certifies that the holdings are not for the purpose of influencing control.